MENU
DNTH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Dianthus Therapeutics (DNTH) Ownership - Who owns Dianthus Therapeutics?
Profile
Industry
N/A
Address
7 Times Square
Phone
+1 929 999-4055
Employees
53
Web
https://www.dianthustx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
718.32M
P/E Ratio
3.36
Total Cash
281.12M
Projected Growth
N/A
Total Debt
311K
Revenue
5.37M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
9.50
Total Debt/Equity
N/A
Revenue/Share
0.19 USD as % of share price
Fundamentals
DNTH
Capitalization
718M
P/E Ratio
3.36
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
281M
Total Cash/Share
9.50
Total Debt
311K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.19%
Revenue
5.37M
ROE
N/A
Book Value
338M
P/B Ratio
2.13
Cash Flow
N/A
Earnings
7.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
29K
Current Ratio
18.30
Current Revenue Per Employee
40981.13
Dividends Per Share - Security
N/A
EBITDA
-82.47M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-24.54
Shares Held By Institutions
1.03B
Shares Outstanding - Current
29.6M
Total Liabilities
16.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
133.365
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
7 Times Square
Phone
+1 929 999-4055
Employees
53
Web
https://www.dianthustx.com